Abbott and Bigfoot Biomedical collaborate on diabetes management systems

Abbott and Bigfoot Biomedical announced an agreement to develop and commercialize diabetes management systems integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States.

“This collaboration brings people living with diabetes a significant step closer to the ultimate goal of eliminating much of the daily burden of diabetes management.”prnewswire.com

• 1 source
• prnewswire.comAbbott and Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes TechnologiesAbbottJul 13, 2017

Summarized from public sources; check the original articles before acting on it.